Hypertension and sleep: Overview of a tight relationship

Sleep Medicine Reviews

Volumn 18, Issue 6, 2014, Pages 509-519

  Pepin, Jean Louis ^a,b   Borel, Anne Laure ^a,b   Tamisier, Renaud ^a,b   Baguet, Jean Philippe ^b   Levy, Patrick ^a,b   Dauvilliers, Yves ^c  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Hypertension; Insomnia; Narcolepsy; Obstructive sleep apnea syndrome; Restless legs syndrome; Sleep; Sleep duration

Indexed keywords

CATAPLEXY; HUMAN; HYPERTENSION; INSOMNIA; NARCOLEPSY; PERIODIC LIMB MOVEMENT DISORDER; RESTLESS LEGS SYNDROME; REVIEW; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP TIME; COMPLICATION; PARASOMNIA; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP STAGE;

HUMANS; HYPERTENSION; NARCOLEPSY; NOCTURNAL MYOCLONUS SYNDROME; RESTLESS LEGS SYNDROME; SLEEP; SLEEP APNEA, OBSTRUCTIVE; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP STAGES;

EID: 84923263129     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2014.03.003     Document Type: Review

References (109)

1. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
2. Lawes C.M., Vander Hoorn S., Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008, 371:1513-1518.
3. Fuchs F.D. Prehypertension: the rationale for early drug therapy. Cardiovasc Ther 2010, 28:339-343.
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAm Med Assoc 2003, 289:2560-2572.
5. Yano Y., Kario K. Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertens Res 2012, 35:695-701.
6. Legramante J.M., Galante A. Sleep and hypertension: a challenge for the autonomic regulation of the cardiovascular system. Circulation 2005, 112:786-788.
7. Lombardi F., Parati G. An update on: cardiovascular and respiratory changes during sleep in normal and hypertensive subjects. Cardiovasc Res 2000, 45:200-211.
8. Hornyak M., Cejnar M., Elam M., Matousek M., Wallin B.G. Sympathetic muscle nerve activity during sleep in man. Brain 1991, 114(Pt 3):1281-1295.
9. Somers V.K., Dyken M.E., Mark A.L., Abboud F.M. Sympathetic-nerve activity during sleep in normal subjects. NEngl J Med 1993, 328:303-307.
10. Sayk F., Teckentrup C., Becker C., Heutling D., Wellhoner P., Lehnert H., et al. Effects of selective slow-wave sleep deprivation on nocturnal blood pressure dipping and daytime blood pressure regulation. Am J Physiol Regul Integr Comp Physiol 2010, 298:R191-R197.
11. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. NEngl J Med 2000, 342:1378-1384.
12. Marin J.M., Agusti A., Villar I., Forner M., Nieto D., Carrizo S.J., et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAm Med Assoc 2012, 307:2169-2176.
13. Baguet J.P., Hammer L., Levy P., Pierre H., Rossini E., Mouret S., et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. JHypertens 2005, 23:521-527.
14. Baguet J.P., Levy P., Barone-Rochette G., Tamisier R., Pierre H., Peeters M., et al. Masked hypertension in obstructive sleep apnea syndrome. JHypertens 2008, 26:885-892.
15. Baguet J.P., Boutin I., Barone-Rochette G., Levy P., Tamisier R., Pierre H., et al. Hypertension diagnosis in obstructive sleep apnea: self or 24-hour ambulatory blood pressure monitoring?. Int J Cardiol 2013, 167(5):2346-2347.
16. Lozano L., Tovar J.L., Sampol G., Romero O., Jurado M.J., Segarra A., et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. JHypertens 2010, 28:2161-2168.
17. Pedrosa R.P., Drager L.F., Gonzaga C.C., Sousa M.G., de Paula L.K., Amaro A.C., et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011, 58:811-817.
18. Bixler E.O., Vgontzas A.N., Lin H.M., Liao D., Calhoun S., Fedok F., et al. Blood pressure associated with sleep-disordered breathing in a population sample of children. Hypertension 2008, 52:841-846.
19. Amin R., Somers V.K., McConnell K., Willging P., Myer C., Sherman M., et al. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension 2008, 51:84-91.
20. Li A.M., Au C.T., Ho C., Fok T.F., Wing Y.K. Blood pressure is elevated in children with primary snoring. JPediatr 2009, 155:362-368. e361.
21. Kaditis A.G., Alexopoulos E.I., Kostadima E., Kaditis D.G., Pastaka C., Zintzaras E., et al. Comparison of blood pressure measurements in children with and without habitual snoring. Pediatr Pulmonol 2005, 39:408-414.
22. Bixler E.O., Vgontzas A.N., Lin H.M., Ten Have T., Leiby B.E., Vela-Bueno A., et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000, 160:2289-2295.
23. Chouchou F., Pichot V., Pepin J.L., Tamisier R., Celle S., Maudoux D., et al. Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects: the PROOF-SYNAPSE study. Eur Heart J 2013, 34:2122-2131. 2131a.
24. Punjabi N.M., Caffo B.S., Goodwin J.L., Gottlieb D.J., Newman A.B., O'Connor G.T., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6:e1000132.
25. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
26. Lavie P., Lavie L., Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 2005, 25:514-520.
27. Rich J., Raviv A., Raviv N., Brietzke S.E. All-cause mortality and obstructive sleep apnea severity revisited. Otolaryngol Head Neck Surg 2012, 147:583-587.
28. Martinez-Garcia M.A., Campos-Rodriguez F., Catalan-Serra P., Soler-Cataluna J.J., Almeida-Gonzalez C., De la Cruz Moron I., et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. Am J Respir Crit Care Med 2012, 186:909-916.
29. Gooneratne N.S., Richards K.C., Joffe M., Lam R.W., Pack F., Staley B., et al. Sleep disordered breathing with excessive daytime sleepiness is a risk factor for mortality in older adults. Sleep 2011, 34:435-442.
30. Haentjens P., Van Meerhaeghe A., Moscariello A., De Weerdt S., Poppe K., Dupont A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007, 167:757-764.
31. Pepin J.L., Tamisier R., Barone-Rochette G., Launois S.H., Levy P., Baguet J.P. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010, 182:954-960.
32. Barbe F., Duran-Cantolla J., Capote F., de la Pena M., Chiner E., Masa J.F., et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010, 181:718-726.
33. Bazzano L.A., Khan Z., Reynolds K., He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
34. Cistulli P.A., Gotsopoulos H., Marklund M., Lowe A.A. Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Med Rev 2004, 8:443-457.
35. Phillips C.L., Grunstein R.R., Darendeliler M.A., Mihailidou A.S., Srinivasan V.K., Yee B.J., et al. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2013, 187:879-887.
36. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535.
37. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338. b1665.
38. Martinez-Garcia M.A., Capote F., Campos-Rodriguez F., Lloberes P., Diaz de Atauri M.J., Somoza M., et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAm Med Assoc 2013, 310:2407-2415.
39. Borel A.L., Nazare J.A., Smith J., Almeras N., Tremblay A., Bergeron J., et al. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity (Silver Spring) 2012, 20:1223-1233.
40. Pepin J.L., Tamisier R., Levy P. Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective. Thorax 2012, 67:1025-1027.
41. Pi-Sunyer X., Blackburn G., Brancati F.L., Bray G.A., Bright R., Clark J.M., et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007, 30:1374-1383.
42. Lusardi P., Mugellini A., Preti P., Zoppi A., Derosa G., Fogari R. Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens 1996, 9:503-505.
43. Tochikubo O., Ikeda A., Miyajima E., Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996, 27:1318-1324.
44. Lusardi P., Zoppi A., Preti P., Pesce R.M., Piazza E., Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am J Hypertens 1999, 12:63-68.
45. Dettoni J.L., Consolim-Colombo F.M., Drager L.F., Rubira M.C., Souza S.B., Irigoyen M.C., et al. Cardiovascular effects of partial sleep deprivation in healthy volunteers. JAppl Physiol (1985) 2012, 113:232-236.
46. Kato M., Phillips B.G., Sigurdsson G., Narkiewicz K., Pesek C.A., Somers V.K. Effects of sleep deprivation on neural circulatory control. Hypertension 2000, 35:1173-1175.
47. Ogawa Y., Kanbayashi T., Saito Y., Takahashi Y., Kitajima T., Takahashi K., et al. Total sleep deprivation elevates blood pressure through arterial baroreflex resetting: a study with microneurographic technique. Sleep 2003, 26:986-989.
48. Carter J.R., Durocher J.J., Larson R.A., DellaValla J.P., Yang H. Sympathetic neural responses to 24-hour sleep deprivation in humans: sex differences. Am J Physiol Heart Circ Physiol 2012, 302:H1991-H1997.
49. Pagani M., Pizzinelli P., Traon A.P., Ferreri C., Beltrami S., Bareille M.P., et al. Hemodynamic, autonomic and baroreflex changes after one night sleep deprivation in healthy volunteers. Auton Neurosci 2009, 145:76-80.
50. Kronholm E., Partonen T., Laatikainen T., Peltonen M., Harma M., Hublin C., et al. Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples. JSleep Res 2008, 17:54-62.
51. Gottlieb D.J., Redline S., Nieto F.J., Baldwin C.M., Newman A.B., Resnick H.E., et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 2006, 29:1009-1014.
52. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreier F., Pickering T.G., et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006, 47:833-839.
53. Knutson K.L., Van Cauter E., Rathouz P.J., Yan L.L., Hulley S.B., Liu K., et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med 2009, 169:1055-1061.
54. Lockley S.W., Skene D.J., Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. JSleep Res 1999, 8:175-183.
55. Cappuccio F.P., Stranges S., Kandala N.B., Miller M.A., Taggart F.M., Kumari M., et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II study. Hypertension 2007, 50:693-700.
56. Wang Q., Xi B., Liu M., Zhang Y., Fu M. Short sleep duration is associated with hypertension risk among adults: a systematic review and meta-analysis. Hypertens Res 2012, 35:1012-1018.
57. van den Berg J.F., Tulen J.H., Neven A.K., Hofman A., Miedema H.M., Witteman J.C., et al. Sleep duration and hypertension are not associated in the elderly. Hypertension 2007, 50:585-589.
58. Guo X., Zheng L., Wang J., Zhang X., Li J., Sun Y. Epidemiological evidence for the link between sleep duration and high blood pressure: a systematic review and meta-analysis. Sleep Med 2013, 14:324-332.
59. Haack M., Serrador J., Cohen D., Simpson N., Meier-Ewert H., Mullington J.M. Increasing sleep duration to lower beat-to-beat blood pressure: a pilot study. JSleep Res 2013, 22(3):295-304.
60. Lanfranchi P.A., Pennestri M.H., Fradette L., Dumont M., Morin C.M., Montplaisir J. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep 2009, 32:760-766.
61. Vgontzas A.N., Liao D., Bixler E.O., Chrousos G.P., Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009, 32:491-497.
62. Fernandez-Mendoza J., Vgontzas A.N., Liao D., Shaffer M.L., Vela-Bueno A., Basta M., et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension 2012, 60:929-935.
63. Gangwisch J.E., Malaspina D., Posner K., Babiss L.A., Heymsfield S.B., Turner J.B., et al. Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence. Am J Hypertens 2010, 23:62-69.
64. Winkelman J.W., Finn L., Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006, 7:545-552.
65. Innes K.E., Selfe T.K., Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med Rev 2012, 16:309-339.
66. Ulfberg J., Nystrom B., Carter N., Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001, 16:1159-1163.
67. Ohayon M.M., Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. JPsychosom Res 2002, 53:547-554.
68. Batool-Anwar S., Malhotra A., Forman J., Winkelman J., Li Y., Gao X. Restless legs syndrome and hypertension in middle-aged women. Hypertension 2011, 58:791-796.
69. Guggisberg A.G., Hess C.W., Mathis J. The significance of the sympathetic nervous system in the pathophysiology of periodic leg movements in sleep. Sleep 2007, 30:755-766.
70. Walter L.M., Foster A.M., Patterson R.R., Anderson V., Davey M.J., Nixon G.M., et al. Cardiovascular variability during periodic leg movements in sleep in children. Sleep 2009, 32:1093-1099.
71. Lindner A., Fornadi K., Lazar A.S., Czira M.E., Dunai A., Zoller R., et al. Periodic limb movements in sleep are associated with stroke and cardiovascular risk factors in patients with renal failure. JSleep Res 2012, 21:297-307.
72. Mirza M., Shen W.K., Sofi A., Jahangir A., Mori N., Tajik A.J. Frequent periodic leg movement during sleep is associated with left ventricular hypertrophy and adverse cardiovascular outcomes. JAm Soc Echocardiogr 2013, 26:783-790.
73. Al-Alawi A., Mulgrew A., Tench E., Ryan C.F. Prevalence, risk factors and impact on daytime sleepiness and hypertension of periodic leg movements with arousals in patients with obstructive sleep apnea. JClin Sleep Med 2006, 2:281-287.
74. Donadio V., Plazzi G., Vandi S., Franceschini C., Karlsson T., Montagna P., et al. Sympathetic and cardiovascular activity during cataplexy in narcolepsy. JSleep Res 2008, 17:458-463.
75. Dauvilliers Y., Arnulf I., Mignot E. Narcolepsy with cataplexy. Lancet 2007, 369:499-511.
76. Nunez A., Rodrigo-Angulo M.L., Andres I.D., Garzon M. Hypocretin/orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis. Curr Neuropharmacol 2009, 7:50-59.
77. Plazzi G., Moghadam K.K., Maggi L.S., Donadio V., Vetrugno R., Liguori R., et al. Autonomic disturbances in narcolepsy. Sleep Med Rev 2011, 15:187-196.
78. Portaluppi F., Tiseo R., Smolensky M.H., Hermida R.C., Ayala D.E., Fabbian F. Circadian rhythms and cardiovascular health. Sleep Med Rev 2012, 16:151-166.
79. Dauvilliers Y., Jaussent I., Krams B., Scholz S., Lado S., Levy P., et al. Non-dipping blood pressure profile in narcolepsy with cataplexy. PLoS One 2012, 7:e38977.
80. Grimaldi D., Calandra-Buonaura G., Provini F., Agati P., Pierangeli G., Franceschini C., et al. Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. Sleep 2012, 35:519-528.
81. Dauvilliers Y. Altered sleep-related blood pressure profile in hypocretin-deficient narcoleptic patients. Sleep 2012, 35:453-454.
82. Bansil P., Kuklina E.V., Merritt R.K., Yoon P.W. Associations between sleep disorders, sleep duration, quality of sleep, and hypertension: results from the National Health and Nutrition Examination Survey, 2005 to 2008. JClin Hypertens (Greenwich) 2011, 13:739-743.
83. Friedman O., Bradley T.D., Ruttanaumpawan P., Logan A.G. Independent association of drug-resistant hypertension to reduced sleep duration and efficiency. Am J Hypertens 2010, 23:174-179.
84. Luyster F.S., Buysse D.J., Strollo P.J. Comorbid insomnia and obstructive sleep apnea: challenges for clinical practice and research. JClin Sleep Med 2010, 6:196-204.
85. Sukegawa M., Noda A., Sugiura T., Nakata S., Yoshizaki S., Soga T., et al. Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines. Clin Cardiol 2005, 28:519-522.
86. Marrone O., Salvaggio A., Bue A.L., Bonanno A., Riccobono L., Insalaco G., et al. Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea: relationship with nocturnal sympathetic activity. Clin Exp Hypertens 2011, 33:373-380.
87. Imadojemu V.A., Mawji Z., Kunselman A., Gray K.S., Hogeman C.S., Leuenberger U.A. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007, 131:1406-1413.
88. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
89. Ali N.J., Davies R.J., Fleetham J.A., Stradling J.R. Periodic movements of the legs during sleep associated with rises in systemic blood pressure. Sleep 1991, 14:163-165.
90. Moller D.S., Lind P., Strunge B., Pedersen E.B. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003, 16:274-280.
91. Tomfohr L.M., Edwards K.M., Dimsdale J.E. Is obstructive sleep apnea associated with cortisol levels? A systematic review of the research evidence. Sleep Med Rev 2012, 16:243-249.
92. Vgontzas A.N., Pejovic S., Zoumakis E., Lin H.M., Bentley C.M., Bixler E.O., et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. JClin Endocrinol Metab 2007, 92:4199-4207.
93. Henley D.E., Russell G.M., Douthwaite J.A., Wood S.A., Buchanan F., Gibson R., et al. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. JClin Endocrinol Metab 2009, 94:4234-4242.
94. Vgontzas A.N., Tsigos C., Bixler E.O., Stratakis C.A., Zachman K., Kales A., et al. Chronic insomnia and activity of the stress system: a preliminary study. JPsychosom Res 1998, 45:21-31.
95. Vgontzas A.N., Bixler E.O., Lin H.M., Prolo P., Mastorakos G., Vela-Bueno A., et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. JClin Endocrinol Metab 2001, 86:3787-3794.
96. Rodenbeck A., Huether G., Ruther E., Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett 2002, 324:159-163.
97. Riemann D., Klein T., Rodenbeck A., Feige B., Horny A., Hummel R., et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res 2002, 113:17-27.
98. Rodenbeck A., Cohrs S., Jordan W., Huether G., Ruther E., Hajak G. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology (Berl) 2003, 170:423-428.
99. Irwin M.R., Wang M., Campomayor C.O., Collado-Hidalgo A., Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006, 166:1756-1762.
100. van Leeuwen W.M., Lehto M., Karisola P., Lindholm H., Luukkonen R., Sallinen M., et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One 2009, 4:e4589.
101. Coffman T.M. Under pressure: the search for the essential mechanisms of hypertension. Nat Med 2011, 17:1402-1409.
102. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Follett H., Kales A., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. JClin Endocrinol Metab 2004, 89:2119-2126.
103. Haack M., Sanchez E., Mullington J.M. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007, 30:1145-1152.
104. Haack M., Lee E., Cohen D.A., Mullington J.M. Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain. Pain 2009, 145:136-141.
105. Dematteis M., Julien C., Guillermet C., Sturm N., Lantuejoul S., Mallaret M., et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 2008, 177:227-235.
106. Tamisier R., Pepin J.L., Remy J., Baguet J.P., Taylor J.A., Weiss J.W., et al. 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J 2011, 37:119-128.
107. Jurysta F., van de Borne P., Migeotte P.F., Dumont M., Lanquart J.P., Degaute J.P., et al. Astudy of the dynamic interactions between sleep EEG and heart rate variability in healthy young men. Clin Neurophysiol 2003, 114:2146-2155.
108. Legramante J.M., Marciani M.G., Placidi F., Aquilani S., Romigi A., Tombini M., et al. Sleep-related changes in baroreflex sensitivity and cardiovascular autonomic modulation. JHypertens 2003, 21:1555-1561.
109. Davies C.W., Crosby J.H., Mullins R.L., Barbour C., Davies R.J., Stradling J.R. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000, 55:736-740.